Article
Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients
16 Oct 2023
Abstract excerpt
Purpose: To investigate the alterations in the expression of noncoding, micro, and small RNA expression during treatment with oncolytic reovirus in KRAS-mutated colorectal cancer. Methods: Oncolytic reovirus treatment was administered in phase 1 clinical trial (NCT01274624) for 5 days every 28 days, and blood samples were collected before the administration of the reovirus and 48 h, 8 days, and 15 days after its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
